Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Genetic diversity of Bemisia tabaci species colonizing cassava in Central African Republic characterized by analysis of cytochrome c oxidase subunit I.

Tocko-Marabena BK, Silla S, Simiand C, Zinga I, Legg J, Reynaud B, Delatte H.

PLoS One. 2017 Aug 15;12(8):e0182749. doi: 10.1371/journal.pone.0182749. eCollection 2017.

2.

IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10.

Grohmann U, Van Snick J, Campanile F, Silla S, Giampietri A, Vacca C, Renauld JC, Fioretti MC, Puccetti P.

J Immunol. 2000 Apr 15;164(8):4197-203.

3.

CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.

Grohmann U, Fallarino F, Silla S, Bianchi R, Belladonna ML, Vacca C, Micheletti A, Fioretti MC, Puccetti P.

J Immunol. 2001 Jan 1;166(1):277-83.

4.

IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.

Grohmann U, Bianchi R, Belladonna ML, Silla S, Fallarino F, Fioretti MC, Puccetti P.

J Immunol. 2000 Aug 1;165(3):1357-63.

5.

IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo.

Grohmann U, Bianchi R, Belladonna ML, Vacca C, Silla S, Ayroldi E, Fioretti MC, Puccetti P.

J Immunol. 1999 Sep 15;163(6):3100-5.

6.

Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex.

Grohmann U, Belladonna ML, Bianchi R, Orabona C, Silla S, Squillacioti G, Fioretti MC, Puccetti P.

Cancer Immunol Immunother. 1999 Jul;48(4):195-203.

PMID:
10431689
7.
8.

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide.

Grohmann U, Fioretti MC, Bianchi R, Belladonna ML, Ayroldi E, Surace D, Silla S, Puccetti P.

Crit Rev Immunol. 1998;18(1-2):87-98. Review.

PMID:
9419451
9.

Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.

Grohmann U, Silla S, Belladonna ML, Bianchi R, Orabona C, Puccetti P, Fioretti MC.

Cell Immunol. 1997 Nov 1;181(2):109-19.

PMID:
9398398
10.

Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines.

Grohmann U, Bianchi R, Belladonna ML, Silla S, Surace D, Fioretti MC, Puccetti P.

Adv Exp Med Biol. 1997;417:579-82. No abstract available.

PMID:
9286421
11.

IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.

Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P.

J Immunol. 1996 Aug 15;157(4):1589-97.

PMID:
8759743
12.

[3H]aniracetam binds to specific recognition sites in brain membranes.

Fallarino F, Genazzani AA, Silla S, L'Episcopo MR, Camici O, Corazzi L, Nicoletti F, Fioretti MC.

J Neurochem. 1995 Aug;65(2):912-8.

PMID:
7616253
13.

Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity.

Grohmann U, Belladonna ML, Allegrucci M, Silla S, Schiaffella E, Fioretti MC, Puccetti P.

Viral Immunol. 1994;7(4):155-67.

PMID:
7576030

Supplemental Content

Support Center